The oncolytic peptide LTX-315 induces cell death and DAMP release by mitochondria distortion in human melanoma cells
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
// Liv-Marie Eike 1 , Nannan Yang 2 , Øystein Rekdal 1, 3 , Baldur Sveinbjørnsson 1 1 Department of Molecular Inflammation Research, Department of Medical Biology, Faculty of Health Sciences, University of Tromsø, Tromsø, Norway 2 Department of Community Medicine, Faculty of Health University of Tromsø, Tromsø, Norway 3 Lytix Biopharma, Oslo, Norway Correspondence to: Baldur Sveinbjørnsson, e-mail: baldur.sveinbjornsson@uit.no Keywords: oncolytic peptide, DAMPs, melanoma Received: March 25, 2015 Accepted: October 01, 2015 Published: October 13, 2015 ABSTRACT Host defense peptides (HDPs) are naturally occurring molecules found in most species, in which they play a significant role in the first line defense against intruding pathogens, and several HDPs have been shown to possess anticancer activity. Structure-activity relationship studies on the HDP bovine lactoferricin revealed a de novo design of a nonamer peptide LTX-315, with oncolytic properties. In the present study, we investigated the oncolytic activity of LTX-315 in human melanoma cells (A375). LTX-315 induced a rapid plasma membrane disruption and cell death within 2 hours. At a low concentration, fluorescence-labeled LTX-315 was internalized and accumulated in cytoplasmic vacuoles in close proximity to the mitochondria. The mitochondrial membrane potential was shown to depolarize as a consequence of LTX-315 treatment and at ultrastructural level, the mitochondria morphology was significantly altered. Release of danger signals (DAMPs) such as ATP, Cytochrome C and HMGB1 into the cell supernatant of cultured cells was evident minutes after peptide treatment. The oncolytic effect of LTX-315 involving perturbation of both the cell membrane and the mitochondria with subsequent release of DAMPs may highlight the ability of LTX-315 to induce complete regression and long-term protective immune responses as previously reported in experimental animal models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Danger Model: A Renewed Sense of Self
Matzinger, P. (2002) · Science · doi:10.1126/science.1071059 · Cited by 4,205
Immunogenic cell death and DAMPs in cancer therapy
Krysko, D. V., Garg, A. D., Kaczmarek, A., Krysko, O., Agostinis, P., & Vandenabeele, P. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3380 · Cited by 3,223
Calcium, ATP, and ROS: a mitochondrial love-hate triangle
Brookes, P. S., Yoon, Y., Robotham, J. L., Anders, M. W., & Sheu, S.-S. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00139.2004 · Cited by 2,575 · cited 2×
“Reactive Oxygen Species (ROS) have been reported to play important roles in immunogenic cell death [19, 20], and one important source of ROS can be dysfunctional mitochondria [21, 22].”
Cellular mechanisms and physiological consequences of redox-dependent signalling
Holmström, K. M., & Finkel, T. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3801 · Cited by 2,093
Immunogenic and tolerogenic cell death
Green, D. R., Ferguson, T., Zitvogel, L., & Kroemer, G. (2009) · Nature Reviews Immunology · doi:10.1038/nri2545 · Cited by 1,176 · cited 1×
“It has also been implied to decrease the immunogenicity of released HMGB1 by oxidation [23].”
The cancer glycocalyx mechanically primes integrin-mediated growth and survival
Paszek, M. J., DuFort, C. C., Rossier, O., Bainer, R., Mouw, J. K., Godula, K., Hudak, J. E., Lakins, J. N., Wijekoon, A. C., Cassereau, L., et al. (2014) · Nature · doi:10.1038/nature13535 · Cited by 699
Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation
Krysko, D. V., Agostinis, P., Krysko, O., Garg, A. D., Bachert, C., Lambrecht, B. N., & Vandenabeele, P. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.01.005 · Cited by 680 · cited 2×
“The mitochondria are important mediators of inflammation [60, 61, 63, 64] and a source of DAMPs [22, 63, 65, 66].”
Yang, D., Biragyn, A., Hoover, D. M., Lubkowski, J., & Oppenheim, J. J. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104603 · Cited by 572 · cited 1×
“In addition to the bactericidal effects, many HDPs have been shown to have antitumor [3] and antiviral [4] activity, and contribute to both innate and adaptive immunity [5, 6].”
Autophagy-dependent ATP release from dying cells via lysosomal exocytosis
Wang, Y., Martins, I., Ma, Y., Kepp, O., Galluzzi, L., & Kroemer, G. (2013) · Autophagy · doi:10.4161/auto.25873 · Cited by 137
Mitochondrial damage-associated molecular patterns and vascular function
Wenceslau, C. F., McCarthy, C. G., Szasz, T., Spitler, K., Goulopoulou, S., Webb, R. C., & Working Group on DAMPs in Cardiovascular Disease (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu047 · Cited by 135 · cited 1×
“The mitochondria are important mediators of inflammation [60, 61, 63, 64] and a source of DAMPs [22, 63, 65, 66].”
Extracellular cytochrome c, a mitochondrial apoptosis-related protein, induces arthritis
Pullerits, R., Bokarewa, M., Jonsson, I.-M., Verdrengh, M., & Tarkowski, A. (2005) · Rheumatology · doi:10.1093/rheumatology/keh406 · Cited by 86
Cited by
Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors
Galluzzi, L., Humeau, J., Buqué, A., Zitvogel, L., & Kroemer, G. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0413-z · Cited by 1,349
Antimicrobial peptides with selective antitumor mechanisms: prospect for anticancer applications
Deslouches, B., & Di, Y. P. (2017) · Oncotarget · doi:10.18632/oncotarget.16743 · Cited by 390
Riaz Rajoka, M. S., Zhao, H., Lu, Y., Lian, Z., Li, N., Hussain, N., Shao, D., Jin, M., Li, Q., & Shi, J. (2018) · Food & Function · doi:10.1039/c8fo00547h · Cited by 141
Furukawa, N., Yang, W., Chao, A. R., Patil, A., Mirando, A. C., Pandey, N. B., & Popel, A. S. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01932-5 · Cited by 10
Furukawa, N., Yang, W., Chao, A., Patil, A., Mirando, A., Pandey, N., & Popel, A. (2023) · doi:10.21203/rs.3.rs-3335225/v1 · Cited by 10
Metadata
- Authors
- Eike, L.-M., Yang, N., Rekdal, Ø., & Sveinbjørnsson, B.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2015-10-13
- Volume
- 6
- Issue
- 33
- Pages
- 34910-34923
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W1858187709
- Cited by
- 73
- References
- 11
- FWCI
- 3.92
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.